Article Text

Download PDFPDF
Bronchial asthma on Mount Kilimanjaro is not a disadvantage
  1. S Stokes1,2,
  2. N Kalson2,3,
  3. M Earl2,3,
  4. H Frost2,3,
  5. A G Whitehead2,3,
  6. I Tyrrell-Marsh2,4,
  7. A Davies2,3
  1. 1
    University Hospital of North Staffordshire, Stoke-on-Trent, UK
  2. 2
    MARS—Manchester Altitude Research Society
  3. 3
    Manchester University Medical School, Manchester, UK
  4. 4
    Hope Hospital, Salford, UK
  1. Dr S Stokes, c/o Diane Jackson, Clinical Education Centre, University Hospital of North Staffordshire, Stoke-on-Trent ST4 6QG, UK; suzystokes{at}doctors.org.uk

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Every year, an increasing number of people travel to high altitude and travellers with asthma are becoming more common in remote environments.1 It is well recognised that certain situations at high altitude, such as exercising in cold air, may provoke symptoms.2 However, the mountain environment offers a reduced pollutant and allergen load, potentially causing fewer exacerbations.3 Additionally, increased sympathetic tone and adrenocortical output caused by hypoxia counteract bronchospasm. Acetazolamide, used widely by trekkers for the prophylaxis of acute mountain sickness (AMS), has an additional benefit in patients with asthma of reducing airway hyperreactivity.4 To our knowledge, this is the first prospective …

View Full Text

Footnotes

  • Competing interests: None.

  • Ethics approval: Ethics approval was obtained from the Tanzanian Commission for Science and Technology (2005-261-NA-2005-62).

Linked Articles

  • Letters
    A Smyth C Bertenshaw S Lewis I Choonara A Watson